Saudi Food and Drug Authority - Regulatory authority for pharmaceuticals and medical devices in Saudi Arabia
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| Tecartus | Kite Pharma | Cell suspension for infusion | Jan 1, 2025 | Biological |
| Lyrgaba | (Avalon Pharma) Middle East Pharmaceutical Industries Co. Ltd | Capsule, hard | Jan 1, 2025 | Generic |
| Vegzelma | CELLTRION INC | Concentrate for solution for infusion | Jan 1, 2025 | Biological |
| Azitromicina Azevedos | Sofarimex Indústria Química e Farmacêutica, S.A.. | Powder for solution for infusion | Jan 1, 2025 | Generic |
| Xitamet | AJA PHARMACEUTICAL INDUSTRIES | Film-coated tablet | Jan 1, 2025 | Generic |
| Jedara | JERASH PHARMACEUTICALS LIMITED COMPANY | Cream | Jan 1, 2025 | Generic |
| Lazcluze | Janssen cilag SpA | Film-coated tablet | Jan 1, 2025 | Valid |
| Xonvea | Duchesnay Inc | Prolonged-release tablet | Jan 1, 2025 | NCE |
| Zolabri | Hetero Labs Limited Unit – V | Film-coated tablet | Jan 1, 2025 | Generic |
| Zolabri | Hetero Labs Limited Unit – V | Film-coated tablet | Jan 1, 2025 | Generic |
| Zolabri | Hetero Labs Limited Unit – V | Film-coated tablet | Jan 1, 2025 | Generic |
| Vascorin | Emcure Pharmaceuticals Ltd. | Solution for injection/infusion | Jan 1, 2025 | Generic |
| Liv-Gamma | SK Plasma Co. Ltd | Solution for infusion | Jan 1, 2025 | Biological |
| Zolabri | Hetero Labs Limited Unit – V | Film-coated tablet | Jan 1, 2025 | Generic |
| Olesten | MS Pharma | Powder for solution for injection/infusion | Jan 1, 2025 | Generic |
| Zolabri | Hetero Labs Limited Unit – V | Film-coated tablet | Jan 1, 2025 | Generic |
| Zolabri | Hetero Labs Limited Unit – V | Film-coated tablet | Jan 1, 2025 | Generic |
| Vascorin | Emcure Pharmaceuticals Ltd. | Solution for injection/infusion | Jan 1, 2025 | Generic |
| Sitagia | MEDREICH LIMITED Unit 7 | Film-coated tablet | Jan 1, 2025 | Generic |
| Nintib | Cipla Limited | Capsule | Jan 1, 2025 | Generic |
